Post-Transplant Lymphoproliferative Disorder

Category: Critical Care & Surgery / Oncological Complications

Post-transplant lymphoproliferative disorder (PTLD) is a heterogeneous group of lymphoid proliferations that occur after solid organ or hematopoietic stem cell transplantation, primarily due to immunosuppression and Epstein-Barr virus (EBV) reactivation.

Global Prevalence

Varies by organ and immunosuppression; 1-20% in solid organ transplant recipients, higher in pediatric and intestinal transplant recipients (Source: Blood, 2019).

Medical Breakthroughs

Discover the latest clinical trials and treatments for Post-Transplant Lymphoproliferative Disorder on JourneyForHealth.

View Full Analysis